WILLOW GROVE, Pennsylvania—Artificial intelligence (AI) chatbots, digital darkness events and counterfeit medical products are the most significant health care hazards according to the Emergency Care Research Institute (ECRI). ECRI, an independent nonprofit organization, emphasized the importance of “prevention over reaction” in “Top 10 Health Technology Hazards for 2026” report, Jan. 21.
SAN DIEGO—Dexcom, a manufacturer of continuous glucose monitoring (CGM) sensors, announced that it will stop producing the G6 model of their CGM system starting July 1, 2026.
While supplies may be available through local pharmacies or local medical distributors for a while afterwards, Dexcom said it cannot guarantee availability of the G6 after July 1 and is encouraging everyone who uses the G6 to work with their doctor to upgrade to the G7 as soon as they can.
The Dept. of Health and Human Services Office of Inspector General (OIG) published a report on continuous glucose monitors (CGMs) and supplies acquisition cost. In the report, "Medicare Payments for Continuous Glucose Monitors and Supplies Exceeded Supplier Costs and Retail Market Prices, Indicating Medicare Can Save At Least Tens of Millions of Dollars in One Year," the OIG recommends that the Centers for Medicare & Medicaid Services (CMS) seek payment reductions for CGMs and supplies.
SAN DIEGO—DexCom, Inc., a medical device company that manufactures continuous glucose monitoring systems (CGMs) for diabetes management, announced the official launch of the DexCom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States on Monday, Dec. 1.
DALLAS—CCS—a provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions
WASHINGTON—The Centers for Medicare and Medicaid Services (CMS) issued a revised policy (CR 13049) that seeks to update documentation requirements for replacement supplies of beneficiary-owned continuous glucose monitors (CGMs), the American Association for Homecare (AAHomecare) wrote in a newsletter to members.
NEW YORK—Eddii, a health technology company that focuses on diabetes management solutions, announced the launch of its new virtual diabetes care platform, eddii-Care for Adults. The platform, which is for adults living with type one or type two diabetes, has launched in eight states: California, Illinois, Maryland, New Jersey, New York, Oregon, Texas and Washington.
DALLAS—CCS Medical, a clinical solutions and home-delivered medical supplies provider, announced new research results which found patients living with diabetes who use a continuous glucose monitoring (CGM) device stay on therapy longer and have a lower total cost of care when they receive their supplies through a medical benefit.
